MedAlliance

MedAlliance, founded in 2008, is a privately-owned medical technology company. Headquartered in Switzerland, it operates manufacturing facilities in Irvine, California, USA; Glasgow, UK; and Singapore. MedAlliance specializes in the development of breakthrough technologies and the commercialization of advanced drug-device combination products for the treatment of coronary and peripheral artery diseases. MedAlliance has been committed to developing innovative Drug-Eluting Balloons (DEB) for patients with life-threatening coronary and peripheral artery diseases. Utilizing its proprietary breakthrough technology, MedAlliance has found a unique solution to the challenges of controlled-release and sustained-release of Sirolimus through SELUTION SLR™.